Literature DB >> 21987580

Centrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time.

Catherine A Cukras1, Wai T Wong, Rafael Caruso, Denise Cunningham, Wadih Zein, Paul A Sieving.   

Abstract

OBJECTIVE: To study the longitudinal changes in autofluorescence in Stargardt disease to reveal aspects of disease progression not previously evident. Changes in autofluorescence reflect changing fluorophore compositions of lipofuscin and melanin in retinal pigment epithelial cells, which has been hypothesized to contribute to Stargardt disease pathogenesis.
METHODS: We examined the temporospatial patterns of fundus autofluorescence with excitation at both 488 nm (standard fundus autofluorescence) and 795 nm (near-infrared autofluorescence) in a longitudinal case series involving 8 eyes of 4 patients (range of follow-up, 11-57 months; mean, 39 months). Image processing was performed to analyze spatial and temporal cross-modality associations.
RESULTS: Longitudinal fundus autofluorescence imaging of fleck lesions revealed hyperautofluorescent lesions that extended in a centrifugal direction from the fovea with time. Patterns of spread were nonrandom and followed a radial path that left behind a trail of diminishing autofluorescence. Longitudinal near-infrared autofluorescence imaging also demonstrated centrifugal lesion spread but with fewer hyperautofluorescent lesions, suggestive of more transient hyperautofluorescence and more rapid decay at longer wavelengths. Fundus autofluorescence and near-infrared autofluorescence abnormalities were spatially correlated with each other, and together they reflect systematic progressions in fleck distribution and fluorophore composition occurring during the natural history of the disease.
CONCLUSIONS: Stargardt disease fleck lesions do not evolve randomly in location but instead follow consistent patterns of radial expansion and a systematic decay of autofluorescence that reflect changing lipofuscin and melanin compositions in retinal pigment epithelial cells. These progressive foveal-to-peripheral changes are helpful in elucidating molecular and cellular mechanisms underlying Stargardt disease and may constitute potential outcome measures in clinical trials.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987580      PMCID: PMC3768260          DOI: 10.1001/archophthalmol.2011.332

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  33 in total

1.  Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD.

Authors:  Steffen Schmitz-Valckenberg; Almut Bindewald-Wittich; Joanna Dolar-Szczasny; Jens Dreyhaupt; Sebastian Wolf; Hendrik P N Scholl; Frank G Holz
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

2.  Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration.

Authors:  Frank G Holz; Almut Bindewald-Wittich; Monika Fleckenstein; Jens Dreyhaupt; Hendrik P N Scholl; Steffen Schmitz-Valckenberg
Journal:  Am J Ophthalmol       Date:  2006-12-22       Impact factor: 5.258

3.  Lipofuscin and autofluorescence metrics in progressive STGD.

Authors:  R Theodore Smith; Nuno L Gomes; Gaetano Barile; Mihai Busuioc; Noah Lee; Andrew Laine
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-22       Impact factor: 4.799

4.  N-retinylidene-phosphatidylethanolamine is the preferred retinoid substrate for the photoreceptor-specific ABC transporter ABCA4 (ABCR).

Authors:  Seelochan Beharry; Ming Zhong; Robert S Molday
Journal:  J Biol Chem       Date:  2004-10-07       Impact factor: 5.157

5.  Retinal function and loss of autofluorescence in stargardt disease.

Authors:  Janet S Sunness; Joshua N Steiner
Journal:  Retina       Date:  2008-06       Impact factor: 4.256

6.  Retinal pigment epithelium defects in humans and mice with mutations in MYO7A: imaging melanosome-specific autofluorescence.

Authors:  Daniel Gibbs; Artur V Cideciyan; Samuel G Jacobson; David S Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-25       Impact factor: 4.799

7.  A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease.

Authors:  Nuno L Gomes; Vivienne C Greenstein; Joshua N Carlson; Stephen H Tsang; R Theodore Smith; Ronald E Carr; Donald C Hood; Stanley Chang
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-25       Impact factor: 4.799

8.  Ethnic differences in macular pigment density and distribution.

Authors:  Ute E K Wolf-Schnurrbusch; Nicole Röösli; Eva Weyermann; Mirjam R Heldner; Katja Höhne; Sebastian Wolf
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

9.  Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations.

Authors:  Artur V Cideciyan; Malgorzata Swider; Tomas S Aleman; Marisa I Roman; Alexander Sumaroka; Sharon B Schwartz; Edwin M Stone; Samuel G Jacobson
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2007-05       Impact factor: 2.129

10.  Lipofuscin- and melanin-related fundus autofluorescence in patients with ABCA4-associated retinal dystrophies.

Authors:  Simone Kellner; Ulrich Kellner; Bernhard H F Weber; Britta Fiebig; Silke Weinitz; Klaus Ruether
Journal:  Am J Ophthalmol       Date:  2009-02-25       Impact factor: 5.258

View more
  42 in total

1.  Insights into autofluorescence patterns in Stargardt macular dystrophy using ultra-wide-field imaging.

Authors:  Vinod Kumar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-08       Impact factor: 3.117

2.  Treatment of Stargardt disease with dobesilate.

Authors:  Pedro Cuevas; Luis A Outeiriño; Javier Angulo; Guillermo Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-10-12

3.  MAPPING THE DENSE SCOTOMA AND ITS ENLARGEMENT IN STARGARDT DISEASE.

Authors:  Aryeh Bernstein; Janet S Sunness; Carol A Applegate; Elizabeth O Tegins
Journal:  Retina       Date:  2016-09       Impact factor: 4.256

4.  Macular function in macular degenerations: repeatability of microperimetry as a potential outcome measure for ABCA4-associated retinopathy trials.

Authors:  Artur V Cideciyan; Malgorzata Swider; Tomas S Aleman; Willam J Feuer; Sharon B Schwartz; Robert C Russell; Janet D Steinberg; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-21       Impact factor: 4.799

5.  Correlations among near-infrared and short-wavelength autofluorescence and spectral-domain optical coherence tomography in recessive Stargardt disease.

Authors:  Tobias Duncker; Marcela Marsiglia; Winston Lee; Jana Zernant; Stephen H Tsang; Rando Allikmets; Vivienne C Greenstein; Janet R Sparrow
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-23       Impact factor: 4.799

Review 6.  Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations.

Authors:  Frans P M Cremers; Winston Lee; Rob W J Collin; Rando Allikmets
Journal:  Prog Retin Eye Res       Date:  2020-04-09       Impact factor: 21.198

7.  Peripheral Visual Fields in ABCA4 Stargardt Disease and Correlation With Disease Extent on Ultra-widefield Fundus Autofluorescence.

Authors:  Maria Fernanda Abalem; Benjamin Otte; Chris Andrews; Katherine A Joltikov; Kari Branham; Abigail T Fahim; Dana Schlegel; Cynthia X Qian; John R Heckenlively; Thiran Jayasundera
Journal:  Am J Ophthalmol       Date:  2017-10-14       Impact factor: 5.258

8.  Peripheral Pigmented Retinal Lesions in Stargardt Disease.

Authors:  Peter Y Zhao; Maria Fernanda Abalem; Daniel Nadelman; Cynthia X Qian; Kari Branham; Dana Schlegel; Naheed Khan; John R Heckenlively; Thiran Jayasundera
Journal:  Am J Ophthalmol       Date:  2017-12-27       Impact factor: 5.258

9.  Double hyperautofluorescent ring on fundus autofluorescence in ABCA4.

Authors:  Maria Fernanda Abalem; Cynthia X Qian; Kari Branham; Dana Schlegel; Abigail T Fahim; Naheed W Khan; John R Heckenlively; K Thiran Jayasundera
Journal:  Ophthalmic Genet       Date:  2017-07-20       Impact factor: 1.803

10.  Bisretinoids mediate light sensitivity resulting in photoreceptor cell degeneration in mice lacking the receptor tyrosine kinase Mer.

Authors:  Jin Zhao; Keiko Ueda; Marina Riera; Hye Jin Kim; Janet R Sparrow
Journal:  J Biol Chem       Date:  2018-10-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.